Please use this identifier to cite or link to this item:
Title: Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study.
Authors: López-Medrano, F
Fernández-Ruiz, M
Silva, J T
Carver, P L
van Delden, C
Merino, E
Pérez-Saez, M J
Montero, M
Coussement, J
de Abreu Mazzolin, M
Cervera, C
Santos, L
Sabé, N
Scemla, A
Cordero, E
Cruzado-Vega, L
Martín-Moreno, P L
Len, Ó
Rudas, E
de León, A P
Arriola, M
Lauzurica, R
David, M
González-Rico, C
Henríquez-Palop, F
Fortún, J
Nucci, M
Manuel, O
Paño-Pardo, J R
Montejo, M
Muñoz, P
Sánchez-Sobrino, B
Mazuecos, A
Pascual, J
Horcajada, J P
Lecompte, T
Moreno, A
Carratalà, J
Blanes, M
Hernández, D
Fariñas, M C
Andrés, A
Aguado, J M
Spanish Network for Research in Infectious Diseases (REIPI), the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC), the Study Group for Infections in Compromised Hosts (ESGICH) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and the Swiss Transplant Cohort Study (STCS)
Keywords: antibiotic: antifungal;clinical research/practice;complication: infectious;fungal;infection and infectious agents;infectious disease;kidney transplantation/nephrology
metadata.dc.subject.mesh: Aspergillus
Follow-Up Studies
Glomerular Filtration Rate
Graft Rejection
Graft Survival
International Agencies
Invasive Pulmonary Aspergillosis
Kidney Failure, Chronic
Kidney Function Tests
Kidney Transplantation
Middle Aged
Postoperative Complications
Retrospective Studies
Risk Factors
Survival Rate
Transplant Recipients
Issue Date: 31-May-2016
Abstract: The prognostic factors and optimal therapy for invasive pulmonary aspergillosis (IPA) after kidney transplantation (KT) remain poorly studied. We included in this multinational retrospective study 112 recipients diagnosed with probable (75.0% of cases) or proven (25.0%) IPA between 2000 and 2013. The median interval from transplantation to diagnosis was 230 days. Cough, fever, and expectoration were the most common symptoms at presentation. Bilateral pulmonary involvement was observed in 63.6% of cases. Positivity rates for the galactomannan assay in serum and bronchoalveolar lavage samples were 61.3% and 57.1%, respectively. Aspergillus fumigatus was the most commonly identified species. Six- and 12-week survival rates were 68.8% and 60.7%, respectively, and 22.1% of survivors experienced graft loss. Occurrence of IPA within the first 6 months (hazard ratio [HR]: 2.29; p-value = 0.027) and bilateral involvement at diagnosis (HR: 3.00; p-value = 0.017) were independent predictors for 6-week all-cause mortality, whereas the initial use of a voriconazole-based regimen showed a protective effect (HR: 0.34; p-value = 0.007). The administration of antifungal combination therapy had no apparent impact on outcome. In conclusion, IPA entails a dismal prognosis among KT recipients. Maintaining a low clinical suspicion threshold is key to achieve a prompt diagnosis and to initiate voriconazole therapy.
metadata.dc.identifier.doi: 10.1111/ajt.13837
Appears in Collections:Producción 2020

Files in This Item:
There are no files associated with this item.

This item is protected by original copyright

Except where otherwise noted, Items on the Andalusian Health Repository site are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives License.